Dr. Oddis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 5th Ave
# Falk
Pittsburgh, PA 15213Phone+1 412-647-6700
Education & Training
UPMC Medical EducationFellowship, Rheumatology, 1986 - 1987- UPMC Medical EducationFellowship, Rheumatology, 1984 - 1986
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1980 - 1984
Pennsylvania State University College of MedicineClass of 1980
Certifications & Licensure
PA State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Pittsburgh Magazine Castle Connolly, 2005-2011
- Join now to see all
Clinical Trials
- Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Start of enrollment: 2006 Mar 01
- Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis Start of enrollment: 2014 Oct 01
- Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis Start of enrollment: 2018 Dec 17
Publications & Presentations
PubMed
- The role of multicriteria decision analysis in the development of candidate classification criteria for antisynthetase syndrome: analysis from the CLASS project.Giovanni Zanframundo, Eduardo Dourado, Iazsmin Bauer-Ventura, Sara Faghihi-Kashani, Akira Yoshida
Annals of the Rheumatic Diseases. 2025-03-18 - A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses.Didem Saygin, Anjana Chandrasekhara Pillai, Siamak Moghadam-Kia, Chester V Oddis, Dianxu Ren
Rheumatology. 2025-03-01 - Predictors of response to intravenous immunoglobulin in patients with dermatomyositis: the ProDERM study.Christina Charles-Schoeman, Joachim Schessl, Zsuzsanna Bata-Csörgő, Mazen M Dimachkie, Zoltan Griger
Rheumatology. 2025-02-07
Journal Articles
- Author Correction: Treatment in MyositisChester V Oddis, Rohit Aggarwal, Nature
Press Mentions
ACR Convergence: Stronger Than Ever After More Than 8 DecadesJuly 13th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
